Global Edoxaban Tosilate Tablets and Generic Drugs Market Growth 2026-2032
The global Edoxaban Tosilate Tablets and Generic Drugs market size is predicted to grow from US$ 1902 million in 2025 to US$ 2655 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.
Edoxaban is a member of the Novel Oral Anti-Coagulants (NOACs) class of drugs, and is a rapidly acting, oral, selective factor Xa inhibitor. By inhibiting factor Xa, a key protein in the coagulation cascade, edoxaban prevents the stepwise amplification of protein factors needed to form blood clots. It is indicated to reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF) and for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5-10 days of initial therapy with a parenteral anticoagulant. Traditionally, warfarin, a vitamin K antagonist, was used for stroke prevention in these individuals but effective use of this drug is limited by it's delayed onset, narrow therapeutic window, need for regular monitoring and INR testing, and numerous drug-drug and drug-food interactions. This has prompted enthusiasm for newer agents such as dabigatran, apixaban, and rivaroxaban for effective clot prevention. In addition to once daily dosing, the benefits over warfarin also include significant reductions in hemorrhagic stroke and GI bleeding, and improved compliance, which is beneficial as many patients will be on lifelong therapy.
United States market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Edoxaban Tosilate Tablets and Generic Drugs players cover Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Edoxaban Tosilate Tablets and Generic Drugs Industry Forecast? looks at past sales and reviews total world Edoxaban Tosilate Tablets and Generic Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Edoxaban Tosilate Tablets and Generic Drugs sales for 2026 through 2032. With Edoxaban Tosilate Tablets and Generic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Edoxaban Tosilate Tablets and Generic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Edoxaban Tosilate Tablets and Generic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Edoxaban Tosilate Tablets and Generic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Edoxaban Tosilate Tablets and Generic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Edoxaban Tosilate Tablets and Generic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Edoxaban Tosilate Tablets and Generic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Edoxaban Tosilate Tablets and Generic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Edoxaban Tosilate Tablets and Generic Drugs market?
What factors are driving Edoxaban Tosilate Tablets and Generic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Edoxaban Tosilate Tablets and Generic Drugs market opportunities vary by end market size?
How does Edoxaban Tosilate Tablets and Generic Drugs break out by Type, by Application?
Edoxaban is a member of the Novel Oral Anti-Coagulants (NOACs) class of drugs, and is a rapidly acting, oral, selective factor Xa inhibitor. By inhibiting factor Xa, a key protein in the coagulation cascade, edoxaban prevents the stepwise amplification of protein factors needed to form blood clots. It is indicated to reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF) and for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5-10 days of initial therapy with a parenteral anticoagulant. Traditionally, warfarin, a vitamin K antagonist, was used for stroke prevention in these individuals but effective use of this drug is limited by it's delayed onset, narrow therapeutic window, need for regular monitoring and INR testing, and numerous drug-drug and drug-food interactions. This has prompted enthusiasm for newer agents such as dabigatran, apixaban, and rivaroxaban for effective clot prevention. In addition to once daily dosing, the benefits over warfarin also include significant reductions in hemorrhagic stroke and GI bleeding, and improved compliance, which is beneficial as many patients will be on lifelong therapy.
United States market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Edoxaban Tosilate Tablets and Generic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Edoxaban Tosilate Tablets and Generic Drugs players cover Daiichi Sankyo, Menarini Group, Simcere Pharmaceutical, Lunan Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Edoxaban Tosilate Tablets and Generic Drugs Industry Forecast? looks at past sales and reviews total world Edoxaban Tosilate Tablets and Generic Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Edoxaban Tosilate Tablets and Generic Drugs sales for 2026 through 2032. With Edoxaban Tosilate Tablets and Generic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Edoxaban Tosilate Tablets and Generic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Edoxaban Tosilate Tablets and Generic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Edoxaban Tosilate Tablets and Generic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Edoxaban Tosilate Tablets and Generic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Edoxaban Tosilate Tablets and Generic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Edoxaban Tosilate Tablets and Generic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Edoxaban Tosilate Tablets and Generic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 30 mg
- 60 mg
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Daiichi Sankyo
- Menarini Group
- Simcere Pharmaceutical
- Lunan Pharmaceutical Group
What is the 10-year outlook for the global Edoxaban Tosilate Tablets and Generic Drugs market?
What factors are driving Edoxaban Tosilate Tablets and Generic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Edoxaban Tosilate Tablets and Generic Drugs market opportunities vary by end market size?
How does Edoxaban Tosilate Tablets and Generic Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Edoxaban Tosilate Tablets and Generic Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Edoxaban Tosilate Tablets and Generic Drugs by Country/Region, 2021, 2025 & 2032
2.2 Edoxaban Tosilate Tablets and Generic Drugs Segment by Type
2.2.1 30 mg
2.2.2 60 mg
2.2.3 Other
2.2.4 Edoxaban Tosilate Tablets and Generic Drugs Sales by Type
2.2.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sale Price by Type (2021-2026)
2.3 Edoxaban Tosilate Tablets and Generic Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Edoxaban Tosilate Tablets and Generic Drugs Sales by Application
2.3.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Breakdown Data by Company
3.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Company (2021-2026)
3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Company (2021-2026)
3.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sale Price by Company
3.4 Key Manufacturers Edoxaban Tosilate Tablets and Generic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Edoxaban Tosilate Tablets and Generic Drugs Product Location Distribution
3.4.2 Players Edoxaban Tosilate Tablets and Generic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EDOXABAN TOSILATE TABLETS AND GENERIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Edoxaban Tosilate Tablets and Generic Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales Growth
4.4 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales Growth
4.5 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Growth
4.6 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Growth
5 AMERICAS
5.1 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales by Country
5.1.1 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
5.1.2 Americas Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021-2026)
5.2 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026)
5.3 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales by Region
6.1.1 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2026)
6.1.2 APAC Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2021-2026)
6.2 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026)
6.3 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Edoxaban Tosilate Tablets and Generic Drugs by Country
7.1.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
7.1.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021-2026)
7.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026)
7.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs by Country
8.1.1 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Edoxaban Tosilate Tablets and Generic Drugs
10.3 Manufacturing Process Analysis of Edoxaban Tosilate Tablets and Generic Drugs
10.4 Industry Chain Structure of Edoxaban Tosilate Tablets and Generic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Edoxaban Tosilate Tablets and Generic Drugs Distributors
11.3 Edoxaban Tosilate Tablets and Generic Drugs Customer
12 WORLD FORECAST REVIEW FOR EDOXABAN TOSILATE TABLETS AND GENERIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Region
12.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Forecast by Region (2027-2032)
12.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Edoxaban Tosilate Tablets and Generic Drugs Forecast by Type (2027-2032)
12.7 Global Edoxaban Tosilate Tablets and Generic Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolios and Specifications
13.1.3 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 Menarini Group
13.2.1 Menarini Group Company Information
13.2.2 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolios and Specifications
13.2.3 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Menarini Group Main Business Overview
13.2.5 Menarini Group Latest Developments
13.3 Simcere Pharmaceutical
13.3.1 Simcere Pharmaceutical Company Information
13.3.2 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolios and Specifications
13.3.3 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Simcere Pharmaceutical Main Business Overview
13.3.5 Simcere Pharmaceutical Latest Developments
13.4 Lunan Pharmaceutical Group
13.4.1 Lunan Pharmaceutical Group Company Information
13.4.2 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolios and Specifications
13.4.3 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lunan Pharmaceutical Group Main Business Overview
13.4.5 Lunan Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Edoxaban Tosilate Tablets and Generic Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Edoxaban Tosilate Tablets and Generic Drugs by Country/Region, 2021, 2025 & 2032
2.2 Edoxaban Tosilate Tablets and Generic Drugs Segment by Type
2.2.1 30 mg
2.2.2 60 mg
2.2.3 Other
2.2.4 Edoxaban Tosilate Tablets and Generic Drugs Sales by Type
2.2.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sale Price by Type (2021-2026)
2.3 Edoxaban Tosilate Tablets and Generic Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Edoxaban Tosilate Tablets and Generic Drugs Sales by Application
2.3.4.1 Global Edoxaban Tosilate Tablets and Generic Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Edoxaban Tosilate Tablets and Generic Drugs Breakdown Data by Company
3.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Sales Market Share by Company (2021-2026)
3.2 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue by Company (2021-2026)
3.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Edoxaban Tosilate Tablets and Generic Drugs Sale Price by Company
3.4 Key Manufacturers Edoxaban Tosilate Tablets and Generic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Edoxaban Tosilate Tablets and Generic Drugs Product Location Distribution
3.4.2 Players Edoxaban Tosilate Tablets and Generic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EDOXABAN TOSILATE TABLETS AND GENERIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Edoxaban Tosilate Tablets and Generic Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Edoxaban Tosilate Tablets and Generic Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales Growth
4.4 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales Growth
4.5 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales Growth
4.6 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales Growth
5 AMERICAS
5.1 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales by Country
5.1.1 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
5.1.2 Americas Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021-2026)
5.2 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026)
5.3 Americas Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales by Region
6.1.1 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales by Region (2021-2026)
6.1.2 APAC Edoxaban Tosilate Tablets and Generic Drugs Revenue by Region (2021-2026)
6.2 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026)
6.3 APAC Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Edoxaban Tosilate Tablets and Generic Drugs by Country
7.1.1 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
7.1.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021-2026)
7.2 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026)
7.3 Europe Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs by Country
8.1.1 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Edoxaban Tosilate Tablets and Generic Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Edoxaban Tosilate Tablets and Generic Drugs
10.3 Manufacturing Process Analysis of Edoxaban Tosilate Tablets and Generic Drugs
10.4 Industry Chain Structure of Edoxaban Tosilate Tablets and Generic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Edoxaban Tosilate Tablets and Generic Drugs Distributors
11.3 Edoxaban Tosilate Tablets and Generic Drugs Customer
12 WORLD FORECAST REVIEW FOR EDOXABAN TOSILATE TABLETS AND GENERIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Edoxaban Tosilate Tablets and Generic Drugs Market Size Forecast by Region
12.1.1 Global Edoxaban Tosilate Tablets and Generic Drugs Forecast by Region (2027-2032)
12.1.2 Global Edoxaban Tosilate Tablets and Generic Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Edoxaban Tosilate Tablets and Generic Drugs Forecast by Type (2027-2032)
12.7 Global Edoxaban Tosilate Tablets and Generic Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Product Portfolios and Specifications
13.1.3 Daiichi Sankyo Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 Menarini Group
13.2.1 Menarini Group Company Information
13.2.2 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolios and Specifications
13.2.3 Menarini Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Menarini Group Main Business Overview
13.2.5 Menarini Group Latest Developments
13.3 Simcere Pharmaceutical
13.3.1 Simcere Pharmaceutical Company Information
13.3.2 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Product Portfolios and Specifications
13.3.3 Simcere Pharmaceutical Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Simcere Pharmaceutical Main Business Overview
13.3.5 Simcere Pharmaceutical Latest Developments
13.4 Lunan Pharmaceutical Group
13.4.1 Lunan Pharmaceutical Group Company Information
13.4.2 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Product Portfolios and Specifications
13.4.3 Lunan Pharmaceutical Group Edoxaban Tosilate Tablets and Generic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lunan Pharmaceutical Group Main Business Overview
13.4.5 Lunan Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Edoxaban TosilateTablets and Generic Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Edoxaban TosilateTablets and Generic Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30 mg
Table 4. Major Players of 60 mg
Table 5. Major Players of Other
Table 6. Global Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Edoxaban TosilateTablets and Generic Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Edoxaban TosilateTablets and Generic Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global Edoxaban TosilateTablets and Generic Drugs Sale Market Share by Application (2021-2026)
Table 13. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global Edoxaban TosilateTablets and Generic Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Edoxaban TosilateTablets and Generic Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Company (2021-2026)
Table 18. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global Edoxaban TosilateTablets and Generic Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Edoxaban TosilateTablets and Generic Drugs Producing Area Distribution and Sales Area
Table 22. Players Edoxaban TosilateTablets and Generic Drugs Products Offered
Table 23. Edoxaban TosilateTablets and Generic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Edoxaban TosilateTablets and Generic Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Edoxaban TosilateTablets and Generic Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Edoxaban TosilateTablets and Generic Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas Edoxaban TosilateTablets and Generic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas Edoxaban TosilateTablets and Generic Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC Edoxaban TosilateTablets and Generic Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC Edoxaban TosilateTablets and Generic Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC Edoxaban TosilateTablets and Generic Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe Edoxaban TosilateTablets and Generic Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe Edoxaban TosilateTablets and Generic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe Edoxaban TosilateTablets and Generic Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Edoxaban TosilateTablets and Generic Drugs
Table 53. Key Market Challenges & Risks of Edoxaban TosilateTablets and Generic Drugs
Table 54. Key Industry Trends of Edoxaban TosilateTablets and Generic Drugs
Table 55. Edoxaban TosilateTablets and Generic Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Edoxaban TosilateTablets and Generic Drugs Distributors List
Table 58. Edoxaban TosilateTablets and Generic Drugs Customer List
Table 59. Global Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Edoxaban TosilateTablets and Generic Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Edoxaban TosilateTablets and Generic Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Daiichi Sankyo Basic Information, Edoxaban TosilateTablets and Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Daiichi Sankyo Edoxaban TosilateTablets and Generic Drugs Product Portfolios and Specifications
Table 75. Daiichi Sankyo Edoxaban TosilateTablets and Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Daiichi Sankyo Main Business
Table 77. Daiichi Sankyo Latest Developments
Table 78. Menarini Group Basic Information, Edoxaban TosilateTablets and Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Menarini Group Edoxaban TosilateTablets and Generic Drugs Product Portfolios and Specifications
Table 80. Menarini Group Edoxaban TosilateTablets and Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Menarini Group Main Business
Table 82. Menarini Group Latest Developments
Table 83. Simcere Pharmaceutical Basic Information, Edoxaban TosilateTablets and Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Simcere Pharmaceutical Edoxaban TosilateTablets and Generic Drugs Product Portfolios and Specifications
Table 85. Simcere Pharmaceutical Edoxaban TosilateTablets and Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Simcere Pharmaceutical Main Business
Table 87. Simcere Pharmaceutical Latest Developments
Table 88. Lunan Pharmaceutical Group Basic Information, Edoxaban TosilateTablets and Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Lunan Pharmaceutical Group Edoxaban TosilateTablets and Generic Drugs Product Portfolios and Specifications
Table 90. Lunan Pharmaceutical Group Edoxaban TosilateTablets and Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Lunan Pharmaceutical Group Main Business
Table 92. Lunan Pharmaceutical Group Latest Developments
Table 1. Edoxaban TosilateTablets and Generic Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Edoxaban TosilateTablets and Generic Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30 mg
Table 4. Major Players of 60 mg
Table 5. Major Players of Other
Table 6. Global Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Edoxaban TosilateTablets and Generic Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Edoxaban TosilateTablets and Generic Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global Edoxaban TosilateTablets and Generic Drugs Sale Market Share by Application (2021-2026)
Table 13. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global Edoxaban TosilateTablets and Generic Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Edoxaban TosilateTablets and Generic Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Company (2021-2026)
Table 18. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global Edoxaban TosilateTablets and Generic Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Edoxaban TosilateTablets and Generic Drugs Producing Area Distribution and Sales Area
Table 22. Players Edoxaban TosilateTablets and Generic Drugs Products Offered
Table 23. Edoxaban TosilateTablets and Generic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Edoxaban TosilateTablets and Generic Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Edoxaban TosilateTablets and Generic Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global Edoxaban TosilateTablets and Generic Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Edoxaban TosilateTablets and Generic Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas Edoxaban TosilateTablets and Generic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas Edoxaban TosilateTablets and Generic Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC Edoxaban TosilateTablets and Generic Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC Edoxaban TosilateTablets and Generic Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC Edoxaban TosilateTablets and Generic Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe Edoxaban TosilateTablets and Generic Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe Edoxaban TosilateTablets and Generic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe Edoxaban TosilateTablets and Generic Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Edoxaban TosilateTablets and Generic Drugs
Table 53. Key Market Challenges & Risks of Edoxaban TosilateTablets and Generic Drugs
Table 54. Key Industry Trends of Edoxaban TosilateTablets and Generic Drugs
Table 55. Edoxaban TosilateTablets and Generic Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Edoxaban TosilateTablets and Generic Drugs Distributors List
Table 58. Edoxaban TosilateTablets and Generic Drugs Customer List
Table 59. Global Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Edoxaban TosilateTablets and Generic Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Edoxaban TosilateTablets and Generic Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Edoxaban TosilateTablets and Generic Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Edoxaban TosilateTablets and Generic Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Daiichi Sankyo Basic Information, Edoxaban TosilateTablets and Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Daiichi Sankyo Edoxaban TosilateTablets and Generic Drugs Product Portfolios and Specifications
Table 75. Daiichi Sankyo Edoxaban TosilateTablets and Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Daiichi Sankyo Main Business
Table 77. Daiichi Sankyo Latest Developments
Table 78. Menarini Group Basic Information, Edoxaban TosilateTablets and Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Menarini Group Edoxaban TosilateTablets and Generic Drugs Product Portfolios and Specifications
Table 80. Menarini Group Edoxaban TosilateTablets and Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Menarini Group Main Business
Table 82. Menarini Group Latest Developments
Table 83. Simcere Pharmaceutical Basic Information, Edoxaban TosilateTablets and Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Simcere Pharmaceutical Edoxaban TosilateTablets and Generic Drugs Product Portfolios and Specifications
Table 85. Simcere Pharmaceutical Edoxaban TosilateTablets and Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Simcere Pharmaceutical Main Business
Table 87. Simcere Pharmaceutical Latest Developments
Table 88. Lunan Pharmaceutical Group Basic Information, Edoxaban TosilateTablets and Generic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Lunan Pharmaceutical Group Edoxaban TosilateTablets and Generic Drugs Product Portfolios and Specifications
Table 90. Lunan Pharmaceutical Group Edoxaban TosilateTablets and Generic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Lunan Pharmaceutical Group Main Business
Table 92. Lunan Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Edoxaban TosilateTablets and Generic Drugs
Figure 2. Edoxaban TosilateTablets and Generic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Edoxaban TosilateTablets and Generic Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Edoxaban TosilateTablets and Generic Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Edoxaban TosilateTablets and Generic Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country/Region (2025)
Figure 10. Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30 mg
Figure 12. Product Picture of 60 mg
Figure 13. Product Picture of Other
Figure 14. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type in 2026
Figure 15. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Edoxaban TosilateTablets and Generic Drugs Consumed in Hospital
Figure 17. Global Edoxaban TosilateTablets and Generic Drugs Market: Hospital (2021-2026) & (K Units)
Figure 18. Edoxaban TosilateTablets and Generic Drugs Consumed in Clinic
Figure 19. Global Edoxaban TosilateTablets and Generic Drugs Market: Clinic (2021-2026) & (K Units)
Figure 20. Edoxaban TosilateTablets and Generic Drugs Consumed in Other
Figure 21. Global Edoxaban TosilateTablets and Generic Drugs Market: Other (2021-2026) & (K Units)
Figure 22. Global Edoxaban TosilateTablets and Generic Drugs Sale Market Share by Application (2025)
Figure 23. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Application in 2026
Figure 24. Edoxaban TosilateTablets and Generic Drugs Sales by Company in 2026 (K Units)
Figure 25. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Company in 2026
Figure 26. Edoxaban TosilateTablets and Generic Drugs Revenue by Company in 2026 ($ millions)
Figure 27. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Company in 2026
Figure 28. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Edoxaban TosilateTablets and Generic Drugs Sales 2021-2026 (K Units)
Figure 31. Americas Edoxaban TosilateTablets and Generic Drugs Revenue 2021-2026 ($ millions)
Figure 32. APAC Edoxaban TosilateTablets and Generic Drugs Sales 2021-2026 (K Units)
Figure 33. APAC Edoxaban TosilateTablets and Generic Drugs Revenue 2021-2026 ($ millions)
Figure 34. Europe Edoxaban TosilateTablets and Generic Drugs Sales 2021-2026 (K Units)
Figure 35. Europe Edoxaban TosilateTablets and Generic Drugs Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Revenue 2021-2026 ($ millions)
Figure 38. Americas Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country in 2026
Figure 39. Americas Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Country (2021-2026)
Figure 40. Americas Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Figure 41. Americas Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Application (2021-2026)
Figure 42. United States Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Region in 2026
Figure 47. APAC Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Region (2021-2026)
Figure 48. APAC Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Figure 49. APAC Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Application (2021-2026)
Figure 50. China Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. India Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country in 2026
Figure 58. Europe Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Country (2021-2026)
Figure 59. Europe Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Figure 60. Europe Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Application (2021-2026)
Figure 61. Germany Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. France Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Application (2021-2026)
Figure 69. Egypt Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Edoxaban TosilateTablets and Generic Drugs in 2026
Figure 75. Manufacturing Process Analysis of Edoxaban TosilateTablets and Generic Drugs
Figure 76. Industry Chain Structure of Edoxaban TosilateTablets and Generic Drugs
Figure 77. Channels of Distribution
Figure 78. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Forecast by Region (2027-2032)
Figure 79. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Edoxaban TosilateTablets and Generic Drugs
Figure 2. Edoxaban TosilateTablets and Generic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Edoxaban TosilateTablets and Generic Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Edoxaban TosilateTablets and Generic Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Edoxaban TosilateTablets and Generic Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country/Region (2025)
Figure 10. Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30 mg
Figure 12. Product Picture of 60 mg
Figure 13. Product Picture of Other
Figure 14. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type in 2026
Figure 15. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Edoxaban TosilateTablets and Generic Drugs Consumed in Hospital
Figure 17. Global Edoxaban TosilateTablets and Generic Drugs Market: Hospital (2021-2026) & (K Units)
Figure 18. Edoxaban TosilateTablets and Generic Drugs Consumed in Clinic
Figure 19. Global Edoxaban TosilateTablets and Generic Drugs Market: Clinic (2021-2026) & (K Units)
Figure 20. Edoxaban TosilateTablets and Generic Drugs Consumed in Other
Figure 21. Global Edoxaban TosilateTablets and Generic Drugs Market: Other (2021-2026) & (K Units)
Figure 22. Global Edoxaban TosilateTablets and Generic Drugs Sale Market Share by Application (2025)
Figure 23. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Application in 2026
Figure 24. Edoxaban TosilateTablets and Generic Drugs Sales by Company in 2026 (K Units)
Figure 25. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Company in 2026
Figure 26. Edoxaban TosilateTablets and Generic Drugs Revenue by Company in 2026 ($ millions)
Figure 27. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Company in 2026
Figure 28. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Edoxaban TosilateTablets and Generic Drugs Sales 2021-2026 (K Units)
Figure 31. Americas Edoxaban TosilateTablets and Generic Drugs Revenue 2021-2026 ($ millions)
Figure 32. APAC Edoxaban TosilateTablets and Generic Drugs Sales 2021-2026 (K Units)
Figure 33. APAC Edoxaban TosilateTablets and Generic Drugs Revenue 2021-2026 ($ millions)
Figure 34. Europe Edoxaban TosilateTablets and Generic Drugs Sales 2021-2026 (K Units)
Figure 35. Europe Edoxaban TosilateTablets and Generic Drugs Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Revenue 2021-2026 ($ millions)
Figure 38. Americas Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country in 2026
Figure 39. Americas Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Country (2021-2026)
Figure 40. Americas Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Figure 41. Americas Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Application (2021-2026)
Figure 42. United States Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Region in 2026
Figure 47. APAC Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Region (2021-2026)
Figure 48. APAC Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Figure 49. APAC Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Application (2021-2026)
Figure 50. China Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. India Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country in 2026
Figure 58. Europe Edoxaban TosilateTablets and Generic Drugs Revenue Market Share by Country (2021-2026)
Figure 59. Europe Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Figure 60. Europe Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Application (2021-2026)
Figure 61. Germany Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. France Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Edoxaban TosilateTablets and Generic Drugs Sales Market Share by Application (2021-2026)
Figure 69. Egypt Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Edoxaban TosilateTablets and Generic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Edoxaban TosilateTablets and Generic Drugs in 2026
Figure 75. Manufacturing Process Analysis of Edoxaban TosilateTablets and Generic Drugs
Figure 76. Industry Chain Structure of Edoxaban TosilateTablets and Generic Drugs
Figure 77. Channels of Distribution
Figure 78. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Forecast by Region (2027-2032)
Figure 79. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Edoxaban TosilateTablets and Generic Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Edoxaban TosilateTablets and Generic Drugs Revenue Market Share Forecast by Application (2027-2032)
